Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 USD | -4.45% | -1.58% | -38.77% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 63.08M | Sales 2025 * | 66.72M | Capitalization | 196M |
---|---|---|---|---|---|
Net income 2024 * | 11M | Net income 2025 * | 16M | EV / Sales 2024 * | 3.11 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.94 x |
P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
12.3
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.94% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | -4.45% | ||
1 week | -1.58% | ||
Current month | -25.16% | ||
1 month | -26.76% | ||
3 months | -23.92% | ||
6 months | -22.20% | ||
Current year | -38.77% |
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 6.87 | -4.45% | 80,087 |
24-05-22 | 7.19 | +0.98% | 153,643 |
24-05-21 | 7.12 | -2.60% | 114,526 |
24-05-20 | 7.31 | +3.84% | 255,397 |
24-05-17 | 7.04 | -1.12% | 306,769 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.77% | 196M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- FENC Stock